Nobias Therapeutics
An AI-first therapeutics company. Nobias is currently running a phase 2 clinical trial for treating symptoms of anxiety, inattention, and autism in children with 22q11 deletion syndrome.
Nobias Therapeutics Offices
Remote Workspace
Employees work remotely.
United States
